Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 1,444 shares at $15.61 ($23K) on 2021-09-20, disclosed to the SEC on 2021-09-22.
Scheduled sale ($23k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.61 | 617 | $10K | 42.0% |
| 2 | $16.11 | 827 | $13K | 58.0% |
| Total | $15.90 avg | 1,444 | $23K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |